Lv4
490 积分 2023-08-22 加入
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
18小时前
已完结
Claudin 18.2 Targeting: A Pan-Cancer Perspective
11天前
已完结
Clinicopathologic Characteristics of Trop Family Proteins (Trop-2 and EpCAM) in Gastric Carcinoma
11天前
已完结
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies
29天前
已完结
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
2个月前
已完结
CAR-T therapy in solid tumors
2个月前
已完结
Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapy
2个月前
已完结
From molecular design to clinical translation: dual-targeted CAR-T strategies in cancer immunotherapy
2个月前
已完结
Multidimensional analysis reveals predictive markers for CAR-T efficacy
2个月前
已完结
BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies
2个月前
已完结
皖公网安备34019202002308
